Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reduction of toxicity of multi-targeting antifolates

Reduction of toxicity of multi-targeting antifolates

US Patent 9138435 · Granted Sep 22, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy2021
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy2019
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2019
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2019
Tetrahydrofolates in combination with EGFR-inhibitors2017
Reduction of toxicity of multi-targeting antifolates2017
Reduction of toxicity of multi-targeting antifolates2017
Belt buckle arrangement with a belt buckle pivotably mounted on a holder2016